Abstract
Monitoring blood beta-hydroxybutyrate is essential in the diagnosis and management of pediatric diabetic-ketoacidosis. Point-of-care capillary beta-hydroxybutyrate testing requires further evaluation in monitoring ketonemia. Study design: Prospective observational analytical study. Setting: Division of Pediatric Critical Care, Department of Pediatrics, JIPMER in collaboration with the Department of Biochemistry, JIPMER from July 2015 to March 2017. Participants: 48 children
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
